ArticleJournal for immunotherapy of cancer2025

Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+ T-cell responses with a long-lived effector cell phenotype.

Jasmin Hatami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.